ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ¼­ºñ½ºº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Pharmaceutical Cold Chain Logistics Market, By Product, By Application, By Service, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1565705
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 311 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,456,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,375,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,746,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 118¾ï 9,032¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â CAGR 9.80%·Î È®´ë

ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå - ½ÃÀå ¿ªÇÐ

¹é½Å¡¤¹ÙÀÌ¿ÀÀǾàǰ ¹× Ư¼ö ÀǾàǰÀÇ ¼ö¿ä È®´ë°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ Àü¸Á

¹é½Å, ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·áÁ¦, Àν¶¸°, ±âŸ »ý¹°ÇÐÀû Á¦Á¦ µî ¹ÙÀÌ¿ÀÀǾàǰÀº ¿Âµµ º¯È­¿¡ ¹Î°¨ÇϹǷΠÄݵåüÀÎ ¹°·ù°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Àü¹® ÄݵåüÀÎ ¹°·ù ¼­ºñ½ºÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ƯÈ÷ COVID-19¿Í °°Àº ¼¼°èÀû À¯Çິ°ú °°Àº ´ë±Ô¸ð ¹é½Å Á¢Á¾ Ä·ÆäÀÎÀÇ °æ¿ì, Àü ¼¼°è¿¡ ¾ÈÀüÇÏ°Ô Àü´ÞÇϱâ À§ÇÑ ÄݵåüÀÎ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çß½À´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA), À¯·´ÀǾàǰû(EMA), ¼¼°èº¸°Ç±â±¸(WHO)¿Í °°Àº ±ÔÁ¦±â°üÀº ¿Âµµ¿¡ ¹Î°¨ÇÑ ÀǾàǰÀÇ ¿î¼Û ¹× º¸°ü¿¡ ´ëÇÑ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» Á¦Á¤Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦·Î ÀÎÇØ ½Å·ÚÇÒ ¼ö ÀÖ°í È¿À²ÀûÀÎ ÄݵåüÀÎ ¹°·ù ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

»ý¹°ÇÐÀû Á¦Á¦ ¹× À¯ÀüÀÚ Ä¡·á¸¦ Æ÷ÇÔÇÑ ¸ÂÃãÇü ÀÇ·á ¹× Ä¡·á·ÎÀÇ ÀüȯÀº ÀÌ·¯ÇÑ °íºÎ°¡°¡Ä¡ Á¦Ç°ÀÇ °íÀ¯ÇÑ º¸°ü ¿ä°ÇÀ» ÃæÁ·½Ã۱â À§ÇÑ ÄݵåüÀÎ ¹°·ù¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸ð³ëŬ·Î³Î Ç×ü ¹× mRNA ±â¹Ý ÀǾàǰ°ú °°Àº ´õ º¹ÀâÇÑ Á¦Á¦°¡ ½ÃÀå¿¡ ÁøÀÔÇÔ¿¡ µû¶ó ¿Âµµ Á¦¾î ȯ°æÀ» ÅëÇØ Á¦Ç°ÀÇ ¹«°á¼ºÀ» À¯ÁöÇÏ´Â °ÍÀÌ Áß¿äÇØÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ½Ç½Ã°£ ¿Âµµ ¸ð´ÏÅ͸µ, µ¥ÀÌÅÍ ·Î°Å, »ç¹°ÀÎÅͳÝ(IoT) Áö¿ø ¼¾¼­¸¦ ÅëÇØ ÄݵåüÀÎ Á¶°ÇÀÇ À¯Áö ¹× ¸ð´ÏÅ͸µ ´É·ÂÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº Á¦¾àȸ»ç°¡ ±ÔÁ¤ Áؼö¸¦ º¸ÀåÇÏ°í ¿Âµµ ÆíÂ÷·Î ÀÎÇÑ Á¦Ç° ¼Õ½ÇÀ» ¹æÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Á¦¾à ÄݵåüÀÎ ¹°·ù ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 9.80%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° ¼¼ºÐÈ­¿¡ µû¶ó ¹é½Å ºÎ¹®Àº ¹ÙÀÌ·¯½º °¨¿°¿¡ ´ëÇÑ ³ôÀº ¹é½Å ¼ö¿ä·Î ÀÎÇØ 2023³â¿¡ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» º¸¿´½À´Ï´Ù.

¿ëµµº°·Î´Â »ý¹°ÇÐÀû Á¦Á¦°¡ Àü¹® ÄݵåüÀÎ ¹°·ù ¼­ºñ½º¸¦ ÇÊ¿ä·Î ÇϹǷΠ2023³â¿¡´Â »ý¹°ÇÐÀû Á¦Á¦°¡ ÁÖ¿ä ¿ëµµ°¡ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼­ºñ½º ºÐ¾ßº°·Î º¸¸é ÷´Ü Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁü¿¡ µû¶ó 2023³â¿¡´Â â°í °ü¸® ºÐ¾ß°¡ ÁÖ¿ä ¼­ºñ½º ºÐ¾ß·Î ºÎ»óÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ 2023³â ÁÖ¿ä ¼öÀÔ¿øÀ¸·Î ²ÅÇû´Âµ¥, ÀÌ´Â ÇコÄÉ¾î ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ¿ëÀÌÇϱ⠶§¹®ÀÔ´Ï´Ù.

Á¦¾à ÄݵåüÀÎ ¹°·ù ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è Á¦¾à ÄݵåüÀÎ ¹°·ù ½ÃÀåÀº Á¦Ç°, ¿ëµµ, ¼­ºñ½º, Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç°Àº ¹é½Å, ¹ÙÀÌ¿ÀÀǾàǰ, ÀÓ»ó½ÃÇè Àç·á µî ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. ¹é½Å ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ ¼ö¿ä Áõ°¡¿Í ¾ÈÀü ´ëÃ¥ÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¿ëµµº°·Î »ý¹°ÇÐÀû Á¦Á¦, Ư¼ö ÀǾàǰ, ±âŸ µî ¼¼ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦ ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÄݵåüÀÎ ¹°·ù´Â ¿Âµµ¿¡ ¹Î°¨ÇÑ ÀǾàǰÀ» ¾ÈÁ¤ÀûÀ¸·Î º¸°üÇÏ´Â µ¥ ÇʼöÀûÀ̸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¼­ºñ½ºº°·Î â°í, VAS, ¿î¼Û µî ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. â°í ºÎ¹®Àº ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç ¿¹Ãø ±â°£ Áß ³ôÀº ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. â°í ¼­ºñ½º¿¡´Â ÀûÀýÇÑ ¾ÈÀü°ú ´ëÃ¥À» °®Ãá ÀǾàǰ ÄݵåüÀÎ ¹°·ù °ü¸®°¡ ÇÊ¿äÇϸç, ÀÌ´Â ½ÃÀå ¼ö¿ä¸¦ º¸¿ÏÇϰí ÀÖ½À´Ï´Ù.

Á¦¾à ÄݵåüÀÎ ¹°·ù ½ÃÀå - Áö¿ªÀû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ÀǾàǰ ÄݵåüÀÎ ¹°·ùÀÇ °¡Àå Å©°í ¼±µµÀûÀÎ ½ÃÀå Áß ÇϳªÀÔ´Ï´Ù. ÀÌ Áö¿ªÀÇ °­·ÂÇÑ ÇコÄɾî ÀÎÇÁ¶ó, ´ëÇü ¹ÙÀÌ¿ÀÁ¦¾à ±â¾÷ÀÇ Á¸Àç, ³ôÀº ±ÔÁ¦ ±âÁØ µîÀÌ ¿Âµµ °ü¸® ¹°·ù ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àα¸ Áõ°¡, ÀÇ·á ¼ö¿ä Áõ°¡, ÀǾàǰ »ý»ê ´É·Â Áõ°¡·Î ÀÎÇØ ÀǾàǰ ÄݵåüÀÎ ¹°·ù ºÐ¾ß¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ª Áß ÇϳªÀÔ´Ï´Ù.

Á¦¾à ÄݵåüÀÎ ¹°·ù ½ÃÀå - °æÀï»óȲ :

Á¦¾à ÄݵåüÀÎ ¹°·ù ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϸç, ¸¹Àº ±â¾÷ÀÌ ÀǾàǰÀÇ ¿Âµµ °ü¸® ¿î¼Û ¹× º¸°ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Àü¹® ¼­ºñ½º ¹× ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¾÷üµéÀº IoT ±â¹Ý ¼Ö·ç¼Ç, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ, ºí·ÏüÀÎ ±â¼úÀ» µµÀÔÇÏ¿© °¡½Ã¼ºÀ» ³ôÀ̰í, ¿Âµµ Ç¥ÁØÀ» ÁؼöÇϸç, ÀǾàǰ ¿î¼ÛÀÇ ¸®½ºÅ©¸¦ ÁÙÀ̱â À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î FedExÀÇ SenseAware, DHLÀÇ LifeTrack Ç÷§Æû µîÀÌ ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷Àº ƯÈ÷ ¾Æ½Ã¾Æ, ¶óƾ¾Æ¸Þ¸®Ä« µî ½ÅÈï ½ÃÀå¿¡¼­ ³ÃÀå ¹× Ç׿ â°í È®Àå¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù.

2022³â, CEVA Logistics´Â ¿Âµµ °ü¸® â°í¿Í ¿î¼Û Â÷·® °³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çß½À´Ï´Ù.

2023³â, Kuehne NagelÀº ¿Âµµ º¯È­¿¡ ¹Î°¨ÇÑ È­¹°¿¡ ƯȭµÈ ¼Ö·ç¼ÇÀÎ KN PharmaChain¿¡ ÅõÀÚÇÏ¿© ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× À§Çè °ü¸®¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ùÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ù »ê¾÷ Á¶»ç

Á¦5Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå ±¸µµ

Á¦7Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå - Á¦Ç°º°

Á¦8Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå - ¿ëµµº°

Á¦9Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå - ¼­ºñ½ºº°

Á¦10Àå ÀǾàǰ ÄݵåüÀÎ ¹°·ù ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀǾàǰ ÄݵåüÀÎ ¹°·ù ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Pharmaceutical Cold Chain Logistics Market size was valued at USD 11,890.32 Million in 2023, expanding at a CAGR of 9.80% from 2024 to 2032.

Pharmaceutical Cold Chain Logistics refers to the process of transporting and storing temperature-sensitive pharmaceutical products, such as vaccines, biologics, insulin, and certain drugs, under controlled temperature conditions. The goal is to maintain the required low-temperature range throughout the entire supply chain, from manufacturing to the final delivery point, to ensure the efficacy, safety, and stability of these products.

Pharmaceutical Cold Chain Logistics Market- Market Dynamics

Growing demand from vaccines & biopharmaceuticals and specialty drugs is expected to propel market demand

Biopharmaceuticals, such as vaccines, cell and gene therapies, insulin, and other biologics, are sensitive to temperature changes and require cold chain logistics. The rise in demand for these products drives the need for specialized cold chain logistics services. Large-scale vaccination campaigns, especially during global pandemics like COVID-19, have significantly increased the demand for cold chain services to ensure safe delivery worldwide. Regulatory bodies like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and World Health Organization (WHO) have stringent guidelines on the transportation and storage of temperature-sensitive pharmaceuticals. These regulations create a strong need for reliable and efficient cold chain logistics solutions.

The shift toward personalized medicine and therapies, including biologics and gene therapies, has fueled the demand for cold chain logistics to handle the specific storage requirements of these high-value products. As more complex formulations like monoclonal antibodies and mRNA-based drugs enter the market, maintaining product integrity through temperature-controlled environments is critical, which in turn is expected to boost the market growth. Further, Real-time temperature monitoring, data loggers, and IoT (Internet of Things)-enabled sensors have improved the ability to maintain and monitor cold chain conditions. These innovations help pharmaceutical companies ensure compliance and avoid product losses due to temperature excursions.

Pharmaceutical Cold Chain Logistics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.80% over the forecast period (2024-2032)

Based on Product segmentation, the vaccines segment was predicted to show maximum market share in the year 2023, owing to high demand for vaccines in viral infections.

Based on Application segmentation, biologics segment was the leading Application segment in 2023, as they need specialized cold chain logistic services.

Based on Service segmentation, warehousing segment was the leading Service segment in 2023, due to high demand from advanced packaging solutions.

On the basis of region, Asia Pacific was the leading revenue generator in 2023, due to the ease of access to healthcare services.

Pharmaceutical Cold Chain Logistics Market- Segmentation Analysis:

The Global Pharmaceutical Cold Chain Logistics Market is segmented on the basis of Product, Application, Service, and Region.

The market is divided into three categories based on Product: vaccines, biopharmaceuticals, and clinical trial materials. The vaccines segment dominates the market. The increasing demand from the recent COVID-19 crisis and safety measures are boosting market growth.

The market is divided into three categories based on Application: biologics, specialty drugs, and others. The biologics segment dominates the market. The cold chain logistics crucial for ensuring that temperature-sensitive medications which is supporting market growth.

The market is divided into three categories based on Service: warehousing, VAS, and transportation. The warehousing segment dominates the market and is expected to maintain its high dominance during the forecast period. Warehousing services needs pharma cold chain logistics management with proper safety & measures which is supplementing market demand.

Pharmaceutical Cold Chain Logistics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is one of the largest and most advanced markets for pharmaceutical cold chain logistics. The region's strong healthcare infrastructure, presence of major biopharmaceutical companies, and high regulatory standards contribute to the demand for temperature-controlled logistics. Asia-Pacific is one of the fastest-growing regions for pharmaceutical cold chain logistics due to its large population, rising healthcare needs, and growing pharmaceutical manufacturing capacity.

Pharmaceutical Cold Chain Logistics Market- Competitive Landscape:

The Pharmaceutical Cold Chain Logistics market is highly competitive, with numerous companies offering specialized services and solutions to meet the growing demand for temperature-controlled transportation and storage of pharmaceutical products. Market players are adopting IoT-based solutions, real-time monitoring systems, and blockchain technologies to provide greater visibility, ensure compliance with temperature standards, and reduce risks in pharmaceutical transportation. Examples include FedEx's SenseAware and DHL's LifeTrack platform. Key players are investing heavily in expanding their cold storage facilities and temperature-controlled warehouses, particularly in emerging markets like Asia and Latin America.

In 2022, CEVA Logistics invested a significant amount in developing temperature-controlled warehouses and transport vehicles.

In 2023, Kuehne Nagel made an investment in KN PharmaChain, a specialized solution for temperature-sensitive cargo, offering real-time monitoring and risk management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET KEY PLAYERS

GLOBAL PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

GLOBAL PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

GLOBAL PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY SERVICE- MARKET ANALYSIS, 2019-2032

GLOBAL PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

Table of Contents

1. Pharmaceutical Cold Chain Logistics Market Overview

2. Executive Summary

3. Pharmaceutical Cold Chain Logistics Key Market Trends

4. Pharmaceutical Cold Chain Logistics Industry Study

5. Pharmaceutical Cold Chain Logistics Market: COVID-19 Impact Analysis

6. Pharmaceutical Cold Chain Logistics Market Landscape

7. Pharmaceutical Cold Chain Logistics Market - By Product

8. Pharmaceutical Cold Chain Logistics Market - By Application

9. Pharmaceutical Cold Chain Logistics Market - By Service

10. Pharmaceutical Cold Chain Logistics Market- By Geography

11. Key Vendor Analysis- Pharmaceutical Cold Chain Logistics Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â